Celiac Artery Compression Syndrome (Median Arcuate Ligament Syndrome)

Comprehensive Clinical Guide: Celiac Artery Compression Syndrome (Median Arcuate Ligament Syndrome)

1. Introduction and Overview

Celiac Artery Compression Syndrome (CACS), more commonly referred to as Median Arcuate Ligament Syndrome (MALS) or Dunbar Syndrome, is a rare and often controversial clinical entity characterized by the extrinsic compression of the celiac artery trunk by the median arcuate ligament (MAL) of the diaphragm.

The median arcuate ligament is a fibrous arch that connects the diaphragmatic crura on either side of the aortic hiatus. In patients with MALS, this ligament inserts lower than normal, crossing the proximal celiac artery and exerting mechanical pressure. This compression leads to a triad of classic symptoms: postprandial abdominal pain, weight loss, and an abdominal bruit. Because symptoms are often non-specific and overlap with a plethora of gastrointestinal and vascular disorders, MALS is frequently a diagnosis of exclusion, requiring a high index of clinical suspicion.

2. Etiology and Pathophysiology

The Anatomical Mechanism

The pathophysiology of MALS is rooted in the anatomical relationship between the diaphragmatic crura and the celiac axis. Under normal physiological conditions, the median arcuate ligament passes superior to the origin of the celiac artery. In MALS, the ligament sits anterior to the celiac axis, causing:
* Mechanical Stenosis: Physical compression of the vessel lumen, leading to reduced blood flow to the foregut.
* Neural Involvement: Chronic irritation or compression of the celiac ganglion (celiac plexus), which lies in close proximity to the celiac artery. Many experts believe that neurogenic pain—rather than pure ischemia—is the primary driver of the clinical syndrome.

Pathophysiological Theories

1. Ischemic Theory: The compression limits arterial inflow to the stomach, liver, spleen, and pancreas. However, collateral circulation from the superior mesenteric artery (SMA) through the pancreaticoduodenal arcades often mitigates severe ischemia, which explains why overt visceral infarction is rare.
2. Neurogenic Theory: Constant irritation of the celiac plexus results in sympathetic overactivity and chronic neuropathic pain, which is often refractory to standard analgesics.

3. Clinical Presentation and Staging

Standard Clinical Presentation

• Postprandial Pain: Described as a dull, aching, or sharp epigastric pain that begins 15–30 minutes after eating.
• Weight Loss: Often significant (10–20 lbs or more) due to "sitophobia" (fear of eating) to avoid pain.
• Abdominal Bruit: A high-pitched systolic sound heard in the epigastrium, which may change in intensity with respiration (often louder during expiration as the diaphragm moves inferiorly).
• Nausea/Vomiting: Frequent, non-specific gastrointestinal distress.

Clinical Grading (Modified Clinical Severity)

While there is no universally standardized staging system, clinical practitioners often categorize patients based on symptom severity:

4. Differential Diagnosis

Because MALS mimics many common abdominal conditions, clinicians must systematically rule out:
* Gastrointestinal: Peptic ulcer disease, chronic pancreatitis, gallbladder disease (cholecystitis), inflammatory bowel disease, and gastroparesis.
* Vascular: Chronic mesenteric ischemia (atherosclerotic), SMA syndrome, or abdominal aortic aneurysm.
* Neurological: Referred pain from thoracic spine pathology.

5. Diagnostic Methodology

Diagnosis is multimodal, combining anatomical imaging with functional assessment.

Key Diagnostic Tests

1. Duplex Ultrasound (DUS): The first-line screening tool. It measures peak systolic velocity (PSV) in the celiac artery. A PSV >200 cm/s is highly suggestive of significant stenosis.
2. CT Angiography (CTA): The gold standard for visualizing the anatomical compression. It reveals the classic "hooked" appearance of the celiac artery and the proximity of the MAL.
3. Magnetic Resonance Angiography (MRA): Preferred in patients with renal insufficiency or those who require avoidance of ionizing radiation.
4. Celiac Plexus Block (Diagnostic): A temporary injection of local anesthetic into the celiac ganglion. If the patient experiences immediate, albeit temporary, relief, it strongly supports the neurogenic component of the syndrome.

6. Risks, Side Effects, and Contraindications

Surgical Intervention Risks

The definitive treatment is surgical decompression (ligament release) with or without celiac artery revascularization.
* Intraoperative: Hemorrhage (due to proximity to the aorta and celiac trunk), injury to the pancreas or adjacent visceral nerves.
* Postoperative: Persistent pain (if the neurogenic component was not adequately addressed), recurrence of stenosis due to fibrotic scarring, or wound infection.

Contraindications

• Asymptomatic Stenosis: Many patients have incidental celiac artery compression found on imaging but remain asymptomatic. Surgery is strictly contraindicated in these individuals.
• Psychosomatic Comorbidities: Patients with severe, untreated psychiatric disorders may not experience the anticipated relief from surgery, necessitating a multidisciplinary approach before surgical intervention.

7. Long-Term Prognosis

The prognosis for patients undergoing surgical decompression is generally favorable, with success rates ranging from 70% to 85% in carefully selected patients.
* Success Factors: Younger age, shorter duration of symptoms, and a positive response to a celiac plexus block are strong predictors of long-term surgical success.
* Failure Factors: Long-standing disease, extensive fibrotic changes in the celiac ganglion, and the presence of concurrent gastrointestinal motility disorders may lead to persistent, refractory symptoms post-surgery.

8. Frequently Asked Questions (FAQ)

1. Is MALS a hereditary condition?
No, MALS is an anatomical variation related to the development of the diaphragm and the positioning of the celiac trunk. It is not considered a genetic or inherited disease.

2. Can MALS be treated without surgery?
Conservative management is rarely effective for true MALS. While pain management and nutritional support can stabilize a patient, surgery is the only way to address the mechanical compression.

3. What is the difference between MALS and SMA Syndrome?
SMA syndrome involves the compression of the duodenum between the aorta and the superior mesenteric artery. While both are vascular-related abdominal compressions, they involve different anatomical structures and vessel systems.

4. Why is the celiac plexus block important?
It helps differentiate between pain caused by pure ischemia and pain caused by nerve irritation. It serves as a "test drive" for whether surgical decompression will likely resolve the patient's symptoms.

5. How long does the recovery take after MALS surgery?
Recovery typically involves 4–6 weeks for full physical healing, though patients may notice improvements in pain levels within days of the procedure.

6. Does MALS lead to a heart attack or stroke?
No. MALS affects the blood supply to the organs of the foregut, not the heart or the brain.

7. Can the celiac artery grow back into the ligament?
Recurrence is possible, often due to the formation of scar tissue (fibrosis) at the site of the original release. This is why some surgeons perform a "neurolysis" (removal of nerve tissue) alongside the ligament release.

8. What kind of doctor treats MALS?
MALS is typically treated by a multidisciplinary team including Vascular Surgeons, General Surgeons, and Interventional Radiologists.

9. Is the abdominal bruit always present?
No. The absence of a bruit does not rule out MALS. Conversely, a bruit can be present in healthy individuals without clinical symptoms.

10. What is "Sitophobia" and why is it common in MALS?
Sitophobia is the fear of eating. In MALS patients, this is a learned behavior because the patient associates the act of eating with the onset of severe, debilitating epigastric pain.

9. Conclusion

Celiac Artery Compression Syndrome represents a complex intersection of vascular anatomy and neurology. While the diagnosis is challenging due to its mimicry of other gastrointestinal conditions, the use of modern imaging (CTA/DUS) and diagnostic nerve blocks has significantly improved clinical outcomes. Clinicians must maintain a high index of suspicion in patients presenting with unexplained postprandial pain and weight loss, ensuring that anatomical findings are correlated with clinical symptoms before recommending surgical intervention. As with many rare syndromes, a patient-centered, multidisciplinary approach remains the cornerstone of successful management.